OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

LITESPARK-011 Trial: Belzutifan Plus Lenvatinib vs Cabozantinib in Advanced RCC

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

BMS Team Celebrates Accelerated FDA Approval for Multiple Myeloma

Lucy Davis Reveals Incurable Stage 4 Breast Cancer: Diagnosis, Bone Metastases, and What We Know

Oncology News, Insights, Stories by OncoDaily

Iberdomide
Hematology

FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR

Oral SERD
Breast Oncology

Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy

Spider-Man: Brand New Day’s Gene-Silencing Technology: Could It Fight Cancer?
Oncolibrary

Spider-Man: Brand New Day’s Gene-Silencing Technology: Could It Fight Cancer?

Andrea Necchi: Another Option for 2L Therapy of Advanced Clear Cell RCC?

UICC Invests €1.49 Million in Three International Cancer Research Projects

Richard Sullivan: China’s Pharmaceutical Rise Signals a New Global Power Shift

Rb-Driven Transcription Reveals a CDK4/6 Paradox in Breast Cancer

The 7th Emirates Oncology Society Annual Conference 2026

Daraxonrasib Resistance in Pancreatic Cancer Points to New Combination Strategies

Shane Jacobson: New $5.45 Million Fund to Empower the Next Generation of Cancer Scientists

Voices
Kyle Kitchen

Kyle Kitchen: Excited to Present at Pioneering the Next Era of Oncology Care

Hillengass Jens: Honored to Present at the 2026 IMS Annual Meeting and Exposition

Felicia Marie Knaul: UCLA Chancellor And I Had the Joy of Meeting Four UCLA Students Here in Oaxaca

Breaking the Stigma Around Cancer to Encourage Earlier Care - WHO EMRO

JJ Singleton: Drops Brings Together Verified Clinicians, Medically Reviewed Content and People With Lived Experience

Simone Cesaro: Potential of Neonatal Screening for Pediatric Cancer Predisposition

Roupen Odabashian։ Differences Between Clinician and Patient Needs in Health Tech

FDA Approvals
Zenbexus

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

The AORTICHORG 3rd Quarterly Webinar

African Organisation for Research and Training in Cancer (AORTIC)

27 Aug
AORTICHORG

The Meningioma Symposium 2026

Wiener Medizinische Akademie (WMA)

28 Sep
Meningioma Symposium

The 31st Annual Meeting and Education Day of the Society for Neuro-Oncology - SNO 2026

Society for Neuro-Oncology (SNO)

12 Nov
Society for Neuro-Oncology

The IBRI Global Forum

Indiana Biosciences Research Institute (IBRI)

29 Oct
IBRI Global Forum

FDA Panel Review of GRAIL’s Galleri Test

U.S. Food and Drug Administration (FDA)

23 Sep
GRAIL’s Galleri

Immune-oncology
CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Hypoxia and Immunotherapy Resistance: Can HIF Targeting Improve Response?

In Vivo CAR-T Cell Therapy: Clinical Proof of Concept and the Rising Role of AI

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Can Diet and the Gut Microbiome Improve Immunotherapy Response?

Gastrointestinal-Oncology
CAVE GOIM

CAVE and CAVE-2 GOIM Studies: Predictive biomarkers for Cetuximab-Based Rechallenge in mCRC

NETTER-2: First-Line [177Lu]Lu-DOTA-TATE plus Octreotide in Advanced G2-G3 GEP-NETs

Daraxonrasib Resistance in Pancreatic Cancer Points to New Combination Strategies

Five-Year CheckMate 648 Follow-Up: Nivolumab-Based Therapy in Advanced ESCC

Liver Transplantation After Chemotherapy and SIRT in Unresectable iCCA

10 Must-Read Posts In GI Oncology This Week

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

Breast-Oncology
Oral SERD

Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy

Rb-Driven Transcription Reveals a CDK4/6 Paradox in Breast Cancer

ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps

Germline BRCA1 Variants May Impair T Cell Function in Breast Cancer

Radiotherapy in Breast Cancer LMD: Critical Survival Uncertainty

After T-DXd: Why Switching ADC Targets May Not Be Enough

HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer

Lung-Oncology
Rilvegostomig

Rilvegostomig NSCLC: 5 Major Promising Findings From ARTEMIDE-01

Air Pollution and Lung Cancer: Critical Metabolic Clues

Transformed SCLC in EGFR-Mutant NSCLC: Critical Progress in a High-Risk Setting

TP53-Mutated EGFR NSCLC: Powerful PFS Gain With Combination Therapy

Targeted Therapy Resistance in NSCLC: Critical Next Steps

SKYSCRAPER-03 Trial: Critical Setback for TIGIT Consolidation in Stage III NSCLC

HER2 Mutations in NSCLC: Critical Risks of Outdated Terms

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
Iberdomide

FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR

Artificial Intelligence and Digital Pathology in Leukemia Diagnosis

Treatment-Free Remission (TFR) in CML: Who, When, and How?

The Next Frontier in R/R ALL: CAR-T, Bispecifics, and Emerging Strategies

Hematologic Malignancies: Therapeutic Success Amid Epidemiological Failure

Hairy Cell Leukemia (HCL): A Rare Leukemia Treated Well, but Rarely Eradicated

Extramedullary Disease in Multiple Myeloma (EMD): Progress in the Immunotherapy Era

Radiotherapy
TREASURE

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

ESTRO Breast Radiotherapy Target Volumes Prospectively Validated in DBCG Skagen Trial 1

10 Must-Read Posts In Radiotherapy This Week: August 2 -9

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

OncoDaily TV
Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Not To Miss
Emirates Oncology Society

The 7th Emirates Oncology Society Annual Conference 2026

ACS National Lung Cancer Roundtable Sets Priorities for Advanced Imaging in Lung Cancer

Top 10 OncoGrants This Week: Major Funding Opportunities Across Cancer Research

ACS CAN Warns New U.S. Vaccine Order Could Put Cancer Patients and Survivors at Risk

LeukO 2026 to Unite the Global Leukemia Community This September

VIRO 2026 Brings Global Voices Together in Renal Oncology

Novo Nordisk and Amazon Web Services Partner to Accelerate Drug Discovery Through AI

OncoGrants
Clinical Research Mentorship

The Clinical Research Mentorship Program - CRMP 2026

Therapeutic Catalyst

Cancer Research Horizons Childhood Cancer Therapeutic Catalyst 2026

Therapeutic Catalyst

Cancer Research UK Therapeutic Catalyst Awards 2026

KI–Mayo Clinic

Cancer Research KI–Mayo Clinic CCC Synergy Grants 2027–2031

Blue Sky Grant

Cancer Research KI Blue Sky Grant for Innovative Cancer Research and Technology 2026

Professor Award

American Cancer Society Professor Award 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Kathleen Schmeler

Kathleen Schmeler

Oncologists Location Houston, USA
Michael Jefford

Michael Jefford

Oncologists Location Melbourne, Australia
Elie Dib

Elie G. Dib

Oncologists Location Baltimore, USA
Aparna Parikh

Aparna Parikh

Oncologists Location Boston, USA
Justin Stebbing

Justin Stebbing

Oncologists Location London, United Kingdom
Loizos G. Loizou

Loizos G. Loizou

Oncologists Location Nicosia, Cyprus
Hany Ariffin

Hany Ariffin

Oncologists Location Kuala Lumpur, Malaysia
Jay M. Lee

Jay M. Lee

Oncologists Location Los Angeles, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
drug approval

Aydah AlAwadhi: From Immunological Silence to Therapeutic Opportunity

Giuseppe Caruso

Giuseppe Caruso: Phase 3 LITESPARK-011 Shows Progression-Free Survival Benefit in Advanced RCC

Razelle Kurzrock

Razelle Kurzrock: Immunotherapy Efficacy in SMARC-Altered Cancers

Humaid O. Al-Shamsi

Humaid Al-Shamsi: New Study on the Value of PD-1/PD-L1 Immunotherapy

Majid Al-Othman

Majid Al-Othman: New ASTRO 2026 Guidelines Update Radiation Therapy for Pancreatic Cancer

Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries